Neptune Wellness Solutions Inc.

$ Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000095017023033091 Filed on July 17, 2023

Income Statement

Concept	2023 Q4	2023 Q3	2023 Q1

Balance Sheet

Concept	2023 Q4	2023 Q3	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$1.251M	$4.768M	$2.000M
YoY Change	-63.22%	240.59%	-77.01%
Cash & Equivalents	$1.233M	$4.751M	$1.993M
Short-Term Investments	$17.64K	$17.64K	$0.00
Other Short-Term Assets	$1.840M	$2.032M	$1.000M
YoY Change	-36.56%	-66.69%	-75.61%
Inventory	$9.616M	$12.06M	$13.01M
Prepaid Expenses	$1.840M	$2.032M	$1.026M
Receivables	$3.893M	$4.586M	$5.700M
Other Receivables	$0.00	$0.00	$1.800M
Total Short-Term Assets	$16.60M	$23.45M	$23.55M
YoY Change	-41.18%	-16.99%	-37.01%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.035M	$1.163M	$1.403M
YoY Change	-44.41%	-45.79%	-93.46%
Goodwill	$2.483M	$2.429M	$2.426M
YoY Change	-82.75%	-83.08%	-89.05%
Intangibles	$1.309M	$1.390M	$1.607M
YoY Change	-92.45%	-92.19%	-92.58%
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets	$6.426M	$6.646M	$7.378M
YoY Change	-82.02%	-81.92%	-89.08%
TOTAL ASSETS
Total Short-Term Assets	$16.60M	$23.45M	$23.55M
Total Long-Term Assets	$6.426M	$6.646M	$7.378M
Total Assets	$23.03M	$30.09M	$30.93M
YoY Change	-64.0%	-53.71%	-70.53%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$31.37M	$29.83M	$20.50M
YoY Change	42.6%	29.71%	91.59%
Accrued Expenses	$339.6K	$339.6K	$6.900M
YoY Change	-32.08%	-43.4%	-44.35%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$25.98M	$10.21M	$7.538M
YoY Change
Total Short-Term Liabilities	$73.42M	$49.76M	$41.03M
YoY Change	145.91%	53.79%	35.35%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$16.68M	$15.41M
YoY Change	-100.0%	13.56%	32.32%
Other Long-Term Liabilities	$14.00K	$19.00K	$24.00K
YoY Change	-39.13%	-20.83%	-72.94%
Total Long-Term Liabilities	$14.00K	$16.70M	$15.44M
YoY Change	-99.91%	13.5%	31.52%
TOTAL LIABILITIES
Total Short-Term Liabilities	$73.42M	$49.76M	$41.03M
Total Long-Term Liabilities	$14.00K	$16.70M	$15.44M
Total Liabilities	$75.25M	$68.35M	$58.49M
YoY Change	56.62%	38.32%	32.58%
SHAREHOLDERS EQUITY
Retained Earnings	-$383.6M	-$392.8M	-$383.6M
YoY Change	7.42%	9.6%	18.71%
Common Stock	$387.6M	$384.4M	$380.1M
YoY Change	2.25%	1.68%	1.89%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$31.25M	-$16.71M	-$11.94M
YoY Change
Total Liabilities & Shareholders Equity	$23.03M	$30.09M	$30.93M
YoY Change	-64.0%	-53.71%	-70.53%

Cashflow Statement

Concept	2023 Q4	2023 Q3	2023 Q1

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	00-0000000
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001401395
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--03-31
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2022Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember http://fasb.org/us-gaap/2022#ServiceMember
CY2022	us-gaap	Revenue From Contract With Customer Product And Service Extensible List RevenueFromContractWithCustomerProductAndServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember http://fasb.org/us-gaap/2022#ServiceMember
CY2023	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember http://fasb.org/us-gaap/2022#ServiceMember
CY2022	us-gaap	Type Of Cost Good Or Service Extensible List TypeOfCostGoodOrServiceExtensibleList	http://fasb.org/us-gaap/2022#ProductMember http://fasb.org/us-gaap/2022#ServiceMember
CY2023Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityCurrent
CY2022Q1	us-gaap	Operating Lease Liability Current Statement Of Financial Position Extensible List OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityCurrent
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List OperatingLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiabilityNoncurrent
CY2022Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiability
CY2023Q1	us-gaap	Operating Lease Liability Statement Of Financial Position Extensible List OperatingLeaseLiabilityStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2022#OperatingLeaseLiability
CY2023	nept	Intangible Assets Accumulated Depreciation IntangibleAssetsAccumulatedDepreciation	19506060
CY2023	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#GainLossOnDerivativeInstrumentsNetPretax
CY2022	us-gaap	Fair Value Recurring Basis Unobservable Input Reconciliation Asset Liability Gain Loss Statement Of Income Extensible List FairValueRecurringBasisUnobservableInputReconciliationAssetLiabilityGainLossStatementOfIncomeExtensibleList	http://fasb.org/us-gaap/2022#GainLossOnDerivativeInstrumentsNetPretax
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	001-33526
CY2023	dei	Entity Registrant Name EntityRegistrantName	NEPTUNE WELLNESS SOLUTIONS INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	A8
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	545 Promenade du Centropolis
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	Suite 100
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Laval
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	QC
CY2023	dei	Entity Address Country EntityAddressCountry	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	H7T 0A3
CY2023Q1	us-gaap	Assets Assets	30928258
CY2022Q1	us-gaap	Assets Assets	104954722
CY2023	dei	City Area Code CityAreaCode	450
CY2023	dei	Local Phone Number LocalPhoneNumber	687-2262
CY2023	dei	Security12b Title Security12bTitle	Common shares, no par value
CY2023	dei	Trading Symbol TradingSymbol	NEPT
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q3	dei	Entity Public Float EntityPublicFloat	3557010
CY2023Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21822149
CY2023	dei	Auditor Firm AuditorFirmId	85
CY2023	dei	Auditor Name AuditorName	KPMG LLP
CY2023	dei	Auditor Location AuditorLocation	Montréal, QC, Canada
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	1993257
CY2022Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	8726341
CY2023Q1	us-gaap	Short Term Investments ShortTermInvestments	17540
CY2022Q1	us-gaap	Short Term Investments ShortTermInvestments	19255
CY2023Q1	nept	Trade And Other Receivables Current TradeAndOtherReceivablesCurrent	7507333
CY2022Q1	nept	Trade And Other Receivables Current TradeAndOtherReceivablesCurrent	7599584
CY2023Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	1025969
CY2022Q1	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3983427
CY2023Q1	us-gaap	Inventory Net InventoryNet	13006074
CY2022Q1	us-gaap	Inventory Net InventoryNet	17059406
CY2023Q1	us-gaap	Assets Current AssetsCurrent	23550173
CY2022Q1	us-gaap	Assets Current AssetsCurrent	37388013
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1403264
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21448123
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	1941347
CY2022Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	2295263
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1607089
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21655035
CY2023Q1	us-gaap	Goodwill Goodwill	2426385
CY2022Q1	us-gaap	Goodwill Goodwill	22168288
CY2023Q1	nept	Trade And Other Payables Current TradeAndOtherPayablesCurrent	27051561
CY2022Q1	nept	Trade And Other Payables Current TradeAndOtherPayablesCurrent	22700849
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339620
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	641698
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7538369
CY2022Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	285004
CY2023Q1	nept	Provisions Current ProvisionsCurrent	2948340
CY2022Q1	nept	Provisions Current ProvisionsCurrent	1118613
CY2023Q1	nept	Liability Related To Warrants Current LiabilityRelatedToWarrantsCurrent	3156254
CY2022Q1	nept	Liability Related To Warrants Current LiabilityRelatedToWarrantsCurrent	5570530
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	41034144
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	30316694
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2017888
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2063421
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15412895
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11648320
CY2023Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	24000
CY2022Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	88688
CY2023Q1	us-gaap	Liabilities Liabilities	58488927
CY2022Q1	us-gaap	Liabilities Liabilities	44117123
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	11996387
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	11996387
CY2022Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5560829
CY2022Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5560829
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	321946102
CY2022Q1	us-gaap	Common Stock Value CommonStockValue	317051125
CY2023Q1	nept	Warrants Warrants	6155323
CY2022Q1	nept	Warrants Warrants	6079890
CY2023Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	58138914
CY2022Q1	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	55980367
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-14538830
CY2022Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-7814163
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-383641363
CY2022Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-323181697
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	-11939854
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	48115522
CY2023Q1	us-gaap	Minority Interest MinorityInterest	-15620815
CY2022Q1	us-gaap	Minority Interest MinorityInterest	12722077
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27560669
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	60837599
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	30928258
CY2022Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	104954722
CY2023	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	643476
CY2022	us-gaap	Excise And Sales Taxes ExciseAndSalesTaxes	1877543
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51744817
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47695828
CY2023	nept	Royalty Revenues RoyaltyRevenues	818584
CY2022	nept	Royalty Revenues RoyaltyRevenues	1019861
CY2023	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	51937
CY2022	us-gaap	Revenue Not From Contract With Customer Other RevenueNotFromContractWithCustomerOther	81435
CY2023	us-gaap	Revenues Revenues	52615338
CY2022	us-gaap	Revenues Revenues	48797124
CY2023	nept	Subsidies Deducted From Cost Of Sales SubsidiesDeductedFromCostOfSales	0
CY2022	nept	Subsidies Deducted From Cost Of Sales SubsidiesDeductedFromCostOfSales	924644
CY2023	us-gaap	Direct Operating Costs DirectOperatingCosts	49591156
CY2022	us-gaap	Direct Operating Costs DirectOperatingCosts	52561404
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	5498347
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	3772066
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	55089503
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	56333470
CY2023	us-gaap	Gross Profit GrossProfit	-2474165
CY2022	us-gaap	Gross Profit GrossProfit	-7536346
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	484224
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	880151
CY2023	nept	Subsidies Deducted From Selling General And Administrative Expenses SubsidiesDeductedFromSellingGeneralAndAdministrativeExpenses	0
CY2022	nept	Subsidies Deducted From Selling General And Administrative Expenses SubsidiesDeductedFromSellingGeneralAndAdministrativeExpenses	99840
CY2023	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	46424295
CY2022	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	60538424
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	17979060
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1527000
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	14765582
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-15346119
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	424454
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19542436
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3288847
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-172945
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	6469
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-102847698
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-88529881
CY2023	nept	Finance Income FinanceIncome	1445
CY2022	nept	Finance Income FinanceIncome	7123
CY2023	nept	Finance Costs FinanceCosts	3824030
CY2022	nept	Finance Costs FinanceCosts	2143978
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-3156569
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	6434510
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-685708
CY2022	nept	Change In Revaluation Of Marketable Securities ChangeInRevaluationOfMarketableSecurities	107203
CY2023	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	14709805
CY2022	us-gaap	Gain Loss On Derivative Instruments Net Pretax GainLossOnDerivativeInstrumentsNetPretax	7035118
CY2023	nept	Loss On Settlement Of Liability LossOnSettlementOfLiability	120021
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	14045140
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4105352
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88802558
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-84424529
CY2023	us-gaap	Profit Loss ProfitLoss	-88802558
CY2022	us-gaap	Profit Loss ProfitLoss	-84424529
CY2023	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-6724667
CY2022	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	750248
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6724667
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	750248
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-95527225
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-83674281
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-60459666
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-74971745
CY2023	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-28342892
CY2022	us-gaap	Net Income Loss Attributable To Noncontrolling Interest NetIncomeLossAttributableToNoncontrollingInterest	-9452784
CY2023	us-gaap	Profit Loss ProfitLoss	-88802558
CY2022	us-gaap	Profit Loss ProfitLoss	-84424529
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-67184333
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-74218802
CY2023	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-28342892
CY2022	us-gaap	Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest	-9455479
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-95527225
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-83674281
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-5.12
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-15.54
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-5.12
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-15.54
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	11812337
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	11812337
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4824336
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4824336
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	60837599
CY2023	us-gaap	Profit Loss ProfitLoss	-88802558
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	-6724667
CY2023	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-95527225
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	3503582
CY2023	us-gaap	Stock Issued During Period Value Conversion Of Convertible Securities StockIssuedDuringPeriodValueConversionOfConvertibleSecurities	845736
CY2023	nept	Common Shares Issued Value In Exchange Of Services Rendered By Non Employees CommonSharesIssuedValueInExchangeOfServicesRenderedByNonEmployees	-156975
CY2023	nept	Warrants Reclassified From Liability WarrantsReclassifiedFromLiability	37710
CY2023	nept	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1769000
CY2023	nept	Increase Decrease Through Restricted Share Units Released Net Of Withholding Taxes IncreaseDecreaseThroughRestrictedShareUnitsReleasedNetOfWithholdingTaxes	815954
CY2023	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	7128957
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	-27560669
CY2021Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	137545309
CY2022	us-gaap	Profit Loss ProfitLoss	-84424529
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	750248
CY2022	us-gaap	Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest	-83674281
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	7816845
CY2022	nept	Warrants In Exchange Of Services Rendered By Non Employees WarrantsInExchangeOfServicesRenderedByNonEmployees	-178917
CY2022	nept	Increase Decrease Through Restricted Share Units Released Net Of Withholding Taxes IncreaseDecreaseThroughRestrictedShareUnitsReleasedNetOfWithholdingTaxes	-1411515
CY2022	us-gaap	Stockholders Equity Period Increase Decrease StockholdersEquityPeriodIncreaseDecrease	6966571
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	60837599
CY2023	us-gaap	Profit Loss ProfitLoss	-88802558
CY2022	us-gaap	Profit Loss ProfitLoss	-84424529
CY2023	nept	Depreciation Of Property Plant And Equipment DepreciationOfPropertyPlantAndEquipment	1068550
CY2022	nept	Depreciation Of Property Plant And Equipment DepreciationOfPropertyPlantAndEquipment	2723751
CY2023	us-gaap	Operating Lease Cost OperatingLeaseCost	505940
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	710984
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1659323
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3356728
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19542436
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3288847
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	3503582
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	7816845
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	5498347
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	3772066
CY2023	nept	Expected Credit Losses ExpectedCreditLosses	1358133
CY2022	nept	Expected Credit Losses ExpectedCreditLosses	1675390
CY2022	nept	Non Employee Compensation Related To Warrants NonEmployeeCompensationRelatedToWarrants	178917
CY2023	us-gaap	Gain Loss On Sale Of Derivatives GainLossOnSaleOfDerivatives	-3156569
CY2023	nept	Net Finance Expense NetFinanceExpense	3822585
CY2022	nept	Net Finance Expense NetFinanceExpense	2136855
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	6434510
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	117297
CY2022	nept	Change In Revaluation Of Marketable Securities ChangeInRevaluationOfMarketableSecurities	107203
CY2023	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	1445
CY2022	us-gaap	Proceeds From Interest Received ProceedsFromInterestReceived	8649
CY2023	nept	Payment For Interest Paid PaymentForInterestPaid	369468
CY2022	nept	Payment For Interest Paid PaymentForInterestPaid	970900
CY2023	nept	Loss On Settlement Of Liability LossOnSettlementOfLiability	120021
CY2023	nept	Revaluation Of Derivatives RevaluationOfDerivatives	-14709805
CY2022	nept	Revaluation Of Derivatives RevaluationOfDerivatives	-7035118
CY2022	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	14765582
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-15346119
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	424454
CY2023	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	17979060
CY2022	us-gaap	Impairment Of Intangible Assets Finitelived ImpairmentOfIntangibleAssetsFinitelived	1527000
CY2023	nept	Common Shares Issued Value In Exchange Of Services Rendered By Non Employees CommonSharesIssuedValueInExchangeOfServicesRenderedByNonEmployees	-156975
CY2023	nept	Payment Of Lease Liabilities PaymentOfLeaseLiabilities	323246
CY2022	nept	Payment Of Lease Liabilities PaymentOfLeaseLiabilities	703686
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-172945
CY2023	nept	Increase Decrease In Operating Assets And Liabilities IncreaseDecreaseInOperatingAssetsAndLiabilities	-7757734
CY2022	nept	Increase Decrease In Operating Assets And Liabilities IncreaseDecreaseInOperatingAssetsAndLiabilities	3163414
CY2023	us-gaap	Increase Decrease In Income Taxes IncreaseDecreaseInIncomeTaxes	-360
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28565729
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54346127
CY2023	us-gaap	Proceeds From Sale Of Oil And Gas Property And Equipment ProceedsFromSaleOfOilAndGasPropertyAndEquipment	170000
CY2023	nept	Net Proceeds From The Sale Of Cannabis Assets NetProceedsFromTheSaleOfCannabisAssets	3121778
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	931107
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1938870
CY2022	us-gaap	Payments To Acquire Intangible Assets PaymentsToAcquireIntangibleAssets	432714
CY2022	us-gaap	Payments For Proceeds From Investments PaymentsForProceedsFromInvestments	-44360
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	2360671
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-2327224
CY2023	nept	Increase In Loans And Borrowings Net Of Financing Fees IncreaseInLoansAndBorrowingsNetOfFinancingFees	-10366767
CY2023	nept	Payments Related To Withholding Taxes Paid To Settlement Of Non Treasury Rs Us PaymentsRelatedToWithholdingTaxesPaidToSettlementOfNonTreasuryRSUs	574153
CY2022	nept	Payments Related To Withholding Taxes Paid To Settlement Of Non Treasury Rs Us PaymentsRelatedToWithholdingTaxesPaidToSettlementOfNonTreasuryRSUs	1411515
CY2023	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	1500950
CY2022	us-gaap	Payments For Repurchase Of Warrants PaymentsForRepurchaseOfWarrants	636847
CY2023	nept	Proceeds From Exercise Of Options And Pre Funded Warrants ProceedsFromExerciseOfOptionsAndPreFundedWarrants	65
CY2022	nept	Proceeds From Exercise Of Options And Pre Funded Warrants ProceedsFromExerciseOfOptionsAndPreFundedWarrants	650
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	19291733
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	5952288
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	180241
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-389485
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-6733084
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-51110548
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8726341
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	59836889
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1993257
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	8726341
CY2023Q1	us-gaap	Cash Cash	1993257
CY2022Q1	us-gaap	Cash Cash	8726341
CY2023	us-gaap	Profit Loss ProfitLoss	-88800000
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-28600000
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-383600000
CY2022	us-gaap	Profit Loss ProfitLoss	-84400000
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-54300000
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6987865
CY2023Q1	nept	Sales Taxes Receivable Current SalesTaxesReceivableCurrent	981594
CY2023	nept	Cash And Cash Equivalents Original Maturity Description CashAndCashEquivalentsOriginalMaturityDescription	three months or less
CY2022Q4	us-gaap	Assets Of Disposal Group Including Discontinued Operation Current AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent	3203557
CY2023	us-gaap	Gain Loss On Sales Of Assets And Asset Impairment Charges GainLossOnSalesOfAssetsAndAssetImpairmentCharges	-15346119
CY2022Q1	nept	Sales Taxes Receivable Current SalesTaxesReceivableCurrent	497824
CY2023Q1	nept	Accrued And Other Receivables Current AccruedAndOtherReceivablesCurrent	825923
CY2022Q1	nept	Accrued And Other Receivables Current AccruedAndOtherReceivablesCurrent	47985
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5699816
CY2022Q4	nept	Impairment Of Asset Sale And Purchase Agreement ImpairmentOfAssetSaleAndPurchaseAgreement	3790340
CY2022Q4	nept	Impairment Of Asset Sale And Purchase Agreement ImpairmentOfAssetSaleAndPurchaseAgreement	5150000
CY2022Q1	nept	Tax Credits Receivable TaxCreditsReceivable	14487
CY2022Q1	nept	Grants And Subsidies Receivables Current GrantsAndSubsidiesReceivablesCurrent	51423
CY2023Q1	nept	Trade And Other Receivables Current TradeAndOtherReceivablesCurrent	7507333
CY2022Q1	nept	Trade And Other Receivables Current TradeAndOtherReceivablesCurrent	7599584
CY2023	nept	Wage And Rent Subsidies WageAndRentSubsidies	0
CY2022	nept	Wage And Rent Subsidies WageAndRentSubsidies	1024484
CY2022Q1	nept	Wage And Rent Subsidies Receivable WageAndRentSubsidiesReceivable	51423
CY2023Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	16711594
CY2022Q1	us-gaap	Accounts Receivable Gross Current AccountsReceivableGrossCurrent	16620118
CY2023Q1	nept	Trade Receivables Expected Credit Loss TradeReceivablesExpectedCreditLoss	11011778
CY2022Q1	nept	Trade Receivables Expected Credit Loss TradeReceivablesExpectedCreditLoss	9632253
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	5699816
CY2022Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	6987865
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9632253
CY2021Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	7915490
CY2023	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	1358133
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Write Offs FinancingReceivableAllowanceForCreditLossesWriteOffs	2505738
CY2023	us-gaap	Financing Receivable Allowance For Credit Loss Foreign Currency Translation FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation	21392
CY2022	us-gaap	Financing Receivable Allowance For Credit Loss Foreign Currency Translation FinancingReceivableAllowanceForCreditLossForeignCurrencyTranslation	41373
CY2022	us-gaap	Financing Receivable Allowance For Credit Losses Recovery FinancingReceivableAllowanceForCreditLossesRecovery	830348
CY2023Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	11011778
CY2022Q1	us-gaap	Financing Receivable Allowance For Credit Losses FinancingReceivableAllowanceForCreditLosses	9632253
CY2023	nept	Number Of Customers Accounted In Trade Receivables NumberOfCustomersAccountedInTradeReceivables	4
CY2022	nept	Number Of Customers Accounted In Trade Receivables NumberOfCustomersAccountedInTradeReceivables	0
CY2023Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5314450
CY2022Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	7920190
CY2022Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	1016916
CY2023Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7360850
CY2022Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	7974690
CY2023Q1	us-gaap	Other Inventories Spare Parts OtherInventoriesSpareParts	330774
CY2022Q1	us-gaap	Other Inventories Spare Parts OtherInventoriesSpareParts	147610
CY2023Q1	us-gaap	Inventory Net InventoryNet	13006074
CY2022Q1	us-gaap	Inventory Net InventoryNet	17059406
CY2023	us-gaap	Inventory Write Down InventoryWriteDown	5498347
CY2022	us-gaap	Inventory Write Down InventoryWriteDown	3772066
CY2023Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	2724491
CY2022Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	66256220
CY2023Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1321227
CY2022Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	44808097
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1403264
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21448123
CY2023	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	1068550
CY2022	us-gaap	Accumulated Depreciation Depletion And Amortization Sale Of Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationSaleOfPropertyPlantAndEquipment1	2723751
CY2023	us-gaap	Impaired Assets To Be Disposed Of By Method Other Than Sale Amount Of Impairment Loss ImpairedAssetsToBeDisposedOfByMethodOtherThanSaleAmountOfImpairmentLoss	386295
CY2023	us-gaap	Operating Lease Impairment Loss OperatingLeaseImpairmentLoss	424454
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	339620
CY2022Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	641698
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2017888
CY2022Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	2063421
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2357508
CY2022Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2705119
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	35466
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	25201
CY2023	nept	Operating Cash Inflow Payments For Sublease Classified As Operating Lease OperatingCashInflowPaymentsForSubleaseClassifiedAsOperatingLease	49894
CY2022	nept	Operating Cash Inflow Payments For Sublease Classified As Operating Lease OperatingCashInflowPaymentsForSubleaseClassifiedAsOperatingLease	61166
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	945145
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	275840
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M28D
CY2022Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P6Y4M2D
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0847
CY2022Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0569
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	519033
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	510260
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	480398
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	491288
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	287143
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due After Year Five LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive	673107
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	2961229
CY2023Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	603721
CY2023Q1	us-gaap	Operating Lease Liability OperatingLeaseLiability	2357508
CY2023Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	27237797
CY2023Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	6124648
CY2023Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	1607089
CY2023	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P3Y11M23D
CY2023Q1	us-gaap	Goodwill Gross GoodwillGross	21968821
CY2023Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	19542436
CY2023Q1	us-gaap	Goodwill Goodwill	2426385
CY2022Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	49696150
CY2022Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	26514115
CY2022	nept	Intangible Assets Accumulated Depreciation IntangibleAssetsAccumulatedDepreciation	1527000
CY2022Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	21655035
CY2022	us-gaap	Acquired Finite Lived Intangible Assets Weighted Average Useful Life AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife	P7Y8M23D
CY2022Q1	us-gaap	Goodwill Gross GoodwillGross	127442658
CY2022Q1	us-gaap	Goodwill Impaired Accumulated Impairment Loss GoodwillImpairedAccumulatedImpairmentLoss	105274370
CY2022Q1	us-gaap	Goodwill Goodwill	22168288
CY2023	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	1659323
CY2022	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	3356728
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	405646
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	405646
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	405646
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	350020
CY2023Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	40131
CY2021Q1	us-gaap	Goodwill Goodwill	25453372
CY2022	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	3288847
CY2022	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	3763
CY2022Q1	us-gaap	Goodwill Goodwill	22168288
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	19542436
CY2023	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-199467
CY2023Q1	us-gaap	Goodwill Goodwill	2426385
CY2023Q1	us-gaap	Goodwill Goodwill	2426385
CY2022Q1	us-gaap	Goodwill Goodwill	22168288
CY2023	nept	Pre Tax Discount Rate PreTaxDiscountRate	0.116
CY2022Q3	nept	Business Plan Duration BusinessPlanDuration	P3Y
CY2022Q3	nept	Operating Result Growth Rate OperatingResultGrowthRate	0.035
CY2023Q1	nept	Litigation Settlement Expense Payable In Securities LitigationSettlementExpensePayableInSecurities	2750000
CY2023Q1	nept	Litigation Related To Accounts Payable LitigationRelatedToAccountsPayable	3750000
CY2022	us-gaap	Impairment Charge On Reclassified Assets ImpairmentChargeOnReclassifiedAssets	1527000
CY2023Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	20525617
CY2022Q1	us-gaap	Accounts Payable Trade Current AccountsPayableTradeCurrent	10667780
CY2023Q1	nept	Accrued Liabilities And Other Payables AccruedLiabilitiesAndOtherPayables	5262167
CY2022Q1	nept	Accrued Liabilities And Other Payables AccruedLiabilitiesAndOtherPayables	11211335
CY2023Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	1263777
CY2022Q1	us-gaap	Employee Related Liabilities Current And Noncurrent EmployeeRelatedLiabilitiesCurrentAndNoncurrent	576826
CY2022Q1	us-gaap	Debt Longterm And Shortterm Combined Amount DebtLongtermAndShorttermCombinedAmount	244908
CY2023Q1	nept	Trade And Other Payables Current TradeAndOtherPayablesCurrent	27051561
CY2022Q1	nept	Trade And Other Payables Current TradeAndOtherPayablesCurrent	22700849
CY2019	nept	Annual Royalties Percentage Of Sales And Other Revenue AnnualRoyaltiesPercentageOfSalesAndOtherRevenue	0.01
CY2023Q1	nept	Litigation Related To Provision For Royalty Payments LitigationRelatedToProvisionForRoyaltyPayments	963808
CY2022Q1	nept	Litigation Related To Provision For Royalty Payments LitigationRelatedToProvisionForRoyaltyPayments	362809
CY2023	nept	Litigation Related To Provision For Royalty Payment Increased Amount LitigationRelatedToProvisionForRoyaltyPaymentIncreasedAmount	638213
CY2023	nept	Litigation Related To Provision For Currency Translation Adjustments LitigationRelatedToProvisionForCurrencyTranslationAdjustments	-37214
CY2022Q1	nept	Litigation Related To Provision For Royalty Payments Increased Amount LitigationRelatedToProvisionForRoyaltyPaymentsIncreasedAmount	626914
CY2022	nept	Litigation Related To Provision For Currency Translation Adjustments LitigationRelatedToProvisionForCurrencyTranslationAdjustments	4122
CY2022Q3	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	68000
CY2022Q1	us-gaap	Loss Contingency Accrual At Carrying Value LossContingencyAccrualAtCarryingValue	1127024
CY2022Q2	us-gaap	Loss Contingency Settlement Agreement Date LossContingencySettlementAgreementDate	July 13, 2022
CY2022Q2	us-gaap	Loss Contingency Accrual Carrying Value Current LossContingencyAccrualCarryingValueCurrent	543774
CY2022Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	583430
CY2023Q1	nept	Litigation Settlement Balance Payable Amount LitigationSettlementBalancePayableAmount	0
CY2023	nept	Litigation Settlement Description LitigationSettlementDescription	The settlement was subject to court approval and certification by the court of the class. On March 16, 2023 the settlement offer was accepted and the first payment in the amount of $500,000 was paid on March 22, 2023. Two additional payments of $500,000 each were subsequently made, on April 21, 2023 and May 4, 2023. The court has set a final approval hearing on July 28, 2023. Neptune intends to pay the balance of the settlement in securities worth $2,750,000 within 31 days after the Final Approval Order is entered.
CY2023	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	500000
CY2023	nept	Number Of Instalments For Litigation Settlement Expense Payable NumberOfInstalmentsForLitigationSettlementExpensePayable	2
CY2023Q1	nept	Other Provisions For Legal Fees Obligations OtherProvisionsForLegalFeesObligations	1384532
CY2022Q1	nept	Other Provisions For Legal Fees Obligations OtherProvisionsForLegalFeesObligations	155804
CY2023Q1	us-gaap	Proceeds From Issuance Of Senior Long Term Debt ProceedsFromIssuanceOfSeniorLongTermDebt	4000000
CY2023Q1	nept	Class Of Warrant Or Right Number Of Warrants Issued ClassOfWarrantOrRightNumberOfWarrantsIssued	850000
CY2023Q1	nept	Warrant Exercisable Term WarrantExercisableTerm	P5Y
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.53
CY2023Q1	nept	Proceeds To Liabilities Initial Liability ProceedsToLiabilitiesInitialLiability	338320
CY2023Q1	nept	Fair Value Of Senior Notes FairValueOfSeniorNotes	3661680
CY2022Q4	nept	Class Of Warrant Or Right Number Of Warrants Issued ClassOfWarrantOrRightNumberOfWarrantsIssued	3208557
CY2022Q4	nept	Combined Purchase Price For One Common Share And One Warrant CombinedPurchasePriceForOneCommonShareAndOneWarrant	1.87
CY2022Q4	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	1.62
CY2022Q4	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	6000002
CY2022Q4	nept	Net Proceeds From Issuance Of Common Stock NetProceedsFromIssuanceOfCommonStock	5135002
CY2022Q4	nept	Proceeds To Liabilities Initial Liability ProceedsToLiabilitiesInitialLiability	7029614
CY2022Q4	nept	Gain Or Loss On Warrants GainOrLossOnWarrants	1029614
CY2022Q4	us-gaap	Deferred Costs Current And Noncurrent DeferredCostsCurrentAndNoncurrent	865000
CY2022Q2	us-gaap	Proceeds From Warrant Exercises ProceedsFromWarrantExercises	5000002
CY2023	nept	Residual Amount Allocated ResidualAmountAllocated	2126955
CY2023	us-gaap	Legal Fees LegalFees	170739
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.32
CY2022Q3	nept	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	384446
CY2022Q3	nept	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1769000
CY2022Q1	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	8000000.0
CY2021Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	497355
CY2021Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	10462000
CY2022	nept	Class Of Warrant Or Right Number Of Warrants Issued ClassOfWarrantOrRightNumberOfWarrantsIssued	1428574
CY2022	nept	Warrants Issued WarrantsIssued	7585314
CY2022	nept	Revaluation Of Warrants RevaluationOfWarrants	-12633316
CY2022	nept	Movements In Exchange Rates Of Warrants MovementsInExchangeRatesOfWarrants	156532
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1925929
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5570530
CY2022Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	1925929
CY2022Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	5570530
CY2023	nept	Class Of Warrant Or Right Number Of Warrants Issued ClassOfWarrantOrRightNumberOfWarrantsIssued	11158166
CY2023	nept	Warrants Issued WarrantsIssued	14494891
CY2023	nept	Class Of Warrant Or Right Number Of Warrants Exercised ClassOfWarrantOrRightNumberOfWarrantsExercised	1173970
CY2023	nept	Warrants Exercised WarrantsExercised	-1769000
CY2023	nept	Warrants Reclassified To Equity During The Period Shares WarrantsReclassifiedToEquityDuringThePeriodShares	497355
CY2023	nept	Warrants Reclassified To Equity During The Period WarrantsReclassifiedToEquityDuringThePeriod	-37710
CY2023	nept	Revaluation Of Warrants RevaluationOfWarrants	-14709805
CY2023	nept	Movements In Exchange Rates Of Warrants MovementsInExchangeRatesOfWarrants	-392652
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11412770
CY2023Q1	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	3156254
CY2023Q1	us-gaap	Class Of Warrant Or Right Outstanding ClassOfWarrantOrRightOutstanding	11412770
CY2023Q1	nept	Class Of Warrant Or Right Exercisable ClassOfWarrantOrRightExercisable	11412770
CY2023Q1	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.90
CY2023Q2	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	0.33
CY2023Q2	nept	Warrant Exercisable Term WarrantExercisableTerm	P5Y
CY2023Q2	us-gaap	Warrants And Rights Outstanding Maturity Date WarrantsAndRightsOutstandingMaturityDate	2029-06-23
CY2023Q1	nept	Class Of Warrant Or Right Number Of Warrants Issued ClassOfWarrantOrRightNumberOfWarrantsIssued	850000
CY2023Q1	nept	Class Of Warrant Or Right Issued Value ClassOfWarrantOrRightIssuedValue	338320
CY2023Q1	us-gaap	Long Term Debt LongTermDebt	22951264
CY2022Q1	us-gaap	Long Term Debt LongTermDebt	11648320
CY2023Q1	us-gaap	Long Term Debt Current LongTermDebtCurrent	7538369
CY2023Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	15412895
CY2022Q1	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	11648320
CY2023	us-gaap	Interest Expense InterestExpense	1999889
CY2022	us-gaap	Interest Expense InterestExpense	1000000
CY2023	us-gaap	Preferred Stock Dividend Rate Percentage PreferredStockDividendRatePercentage	0.05
CY2023	nept	Residual Amount Allocated ResidualAmountAllocated	2126955
CY2022Q3	us-gaap	Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1	2.32
CY2022Q3	nept	Stock Issued During Period Shares Warrants Exercised StockIssuedDuringPeriodSharesWarrantsExercised	384446
CY2022Q3	nept	Stock Issued During Period Value Warrants Exercised StockIssuedDuringPeriodValueWarrantsExercised	1769000
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	3503582
CY2023	nept	Recovery Of Stock Based Compensation RecoveryOfStockBasedCompensation	-1769805
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	7816845
CY2022	nept	Recovery Of Stock Based Compensation RecoveryOfStockBasedCompensation	-3263437
CY2023	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	1445
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	2050909
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	490146
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	236512
CY2023	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	1810518
CY2022	us-gaap	Income Tax Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary IncomeTaxReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary	1121068
CY2023	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	220551
CY2022	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	474339
CY2022	us-gaap	Interest Income Expense Net InterestIncomeExpenseNet	7123
CY2023	nept	Finance Income FinanceIncome	1445
CY2022	nept	Finance Income FinanceIncome	7123
CY2023	us-gaap	Interest And Debt Expense InterestAndDebtExpense	34783
CY2022	us-gaap	Interest And Debt Expense InterestAndDebtExpense	540143
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	1999889
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	1000000
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	168065
CY2023	nept	Warrants Issuance Costs WarrantsIssuanceCosts	1500950
CY2022	nept	Warrants Issuance Costs WarrantsIssuanceCosts	603835
CY2023	nept	Factoring Fees FactoringFees	120343
CY2023	nept	Finance Costs FinanceCosts	3824030
CY2022	nept	Finance Costs FinanceCosts	2143978
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-88802558
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-84424529
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2650
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2650
CY2023	nept	Tax Expense Income At Applicable Tax Rate TaxExpenseIncomeAtApplicableTaxRate	-23532678
CY2022	nept	Tax Expense Income At Applicable Tax Rate TaxExpenseIncomeAtApplicableTaxRate	-22372500
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	19104611
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	18982099
CY2023	nept	Permanent Difference On Impairment On Goodwill PermanentDifferenceOnImpairmentOnGoodwill	4578508
CY2022	nept	Permanent Difference On Impairment On Goodwill PermanentDifferenceOnImpairmentOnGoodwill	788642
CY2023	nept	Income Tax Reconciliation Permanent Difference Related To Derivative IncomeTaxReconciliationPermanentDifferenceRelatedToDerivative	-3061605
CY2022	nept	Income Tax Reconciliation Permanent Difference Related To Derivative IncomeTaxReconciliationPermanentDifferenceRelatedToDerivative	-1656038
CY2023	nept	Non Deductible And Tax Exempt Items NonDeductibleAndTaxExemptItems	7211
CY2022	nept	Non Deductible And Tax Exempt Items NonDeductibleAndTaxExemptItems	71653
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	1237745
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-855007
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	303316
CY2023Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	87316628
CY2022Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	76346005
CY2023Q1	us-gaap	Deferred Tax Assets Goodwill And Intangible Assets DeferredTaxAssetsGoodwillAndIntangibleAssets	3486240
CY2023Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	159149
CY2022Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	554187
CY2023Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	1184407
CY2022Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	290413
CY2023Q1	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	1311442
CY2022Q1	us-gaap	Deferred Tax Assets Deferred Gain On Sale Leaseback Transaction DeferredTaxAssetsDeferredGainOnSaleLeasebackTransaction	1446462
CY2023Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	2863053
CY2022Q1	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3098560
CY2023Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	4295656
CY2022Q1	us-gaap	Deferred Tax Asset Interest Carryforward DeferredTaxAssetInterestCarryforward	3349307
CY2023Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1251163
CY2022Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1693301
CY2023Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	101867738
CY2022Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	86778235
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	101380008
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83934321
CY2023Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	487730
CY2022Q1	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	2843914
CY2022Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	1921815
CY2023Q1	nept	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	487730
CY2022Q1	nept	Deferred Tax Liabilities Right Of Use Assets DeferredTaxLiabilitiesRightOfUseAssets	767164
CY2022Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	-154935
CY2023Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	487730
CY2022Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	2843914
CY2023Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	101380008
CY2022Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	83934321
CY2023Q1	nept	Realized And Unrealized Capital Losses Carry Forwards RealizedAndUnrealizedCapitalLossesCarryForwards	1807774
CY2022Q1	nept	Realized And Unrealized Capital Losses Carry Forwards RealizedAndUnrealizedCapitalLossesCarryForwards	2060000
CY2023	nept	Schedule Of Participating And Non Participating Warrants ScheduleOfParticipatingAndNonParticipatingWarrants	<p style="margin-left:3.333%;text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:6.0pt;text-align:justify;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">More specifically, the breakdown between participating and non-participating warrants is as follows:</span></p> <table style="margin-left:auto;border-spacing:0;table-layout:fixed;width:97.0%;border-collapse:separate;"> <tr style="visibility:collapse;"> <td style="width:35.8%;"></td> <td style="width:1.94%;"></td> <td style="width:19.46%;"></td> <td style="width:1.94%;"></td> <td style="width:19.46%;"></td> <td style="width:1.94%;"></td> <td style="width:19.46%;"></td> </tr> <tr style="height:9.0pt;"> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Reference</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Number of warrants outstanding</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Number of participating warrants</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:left;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:center;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Number of non-participating warrants</span></p></td> </tr> <tr> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Series A Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">714,287</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">714,287</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Series B Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">714,287</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">714,287</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Series C Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">1,744,319</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">1,744,319</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Series D Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">972,763</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">972,763</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Series E Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">6,417,114</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">6,417,114</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">January 2023 Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">850,000</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">850,000</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Warrants classified as liability</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">11,412,770</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">11,412,770</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Warrants IFF</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">57,143</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">57,143</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Warrants AMI</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">119,286</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">119,286</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">2020 Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">300,926</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">300,926</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">2021 Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">196,429</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">196,429</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">March 2023 Warrants</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">111,111</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">—</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">111,111</span></p></td> </tr> <tr style="height:9.0pt;"> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">Warrants classified as equity</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">784,895</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">497,355</span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="border-top:0.5pt solid rgba(0,0,0,1);background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">287,540</span></p></td> </tr> <tr> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> </tr> <tr style="height:9.0pt;"> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">12,197,665</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">11,910,125</span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);"><p style="text-indent:0.0pt;font-size:9.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="white-space:pre-wrap;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;"> </span></p></td> <td style="background-color:rgba(255,255,255,1);word-break:break-word;white-space:pre-wrap;vertical-align:bottom;border-bottom:0.5pt solid rgba(0,0,0,1);text-align:center;"><p style="text-indent:0.0pt;font-size:10.0pt;margin-top:0.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:right;"><span style="font-size:9.0pt;font-family:"Calibri", sans-serif;background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:9.0pt;font-family:"Calibri", sans-serif;min-width:fit-content;">287,540</span></p></td> </tr> </table>
CY2023	us-gaap	Increase Decrease In Other Operating Liabilities IncreaseDecreaseInOtherOperatingLiabilities	-64688
CY2023	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	7757734
CY2022	us-gaap	Increase Decrease In Operating Capital IncreaseDecreaseInOperatingCapital	-3163414
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Fixed Assets Acquired1 NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1	155352
CY2022	us-gaap	Noncash Or Part Noncash Acquisition Intangible Assets Acquired1 NoncashOrPartNoncashAcquisitionIntangibleAssetsAcquired1	109971
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-60459666
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-74971745
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-60459666
CY2023	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-60459666
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-74971745
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-74971745
CY2023	nept	Weighted Average Number Of Shares Outstandings Basic WeightedAverageNumberOfSharesOutstandingsBasic	11812337
CY2023	nept	Weighted Average Number Of Diluted Shares Outstandings WeightedAverageNumberOfDilutedSharesOutstandings	11812337
CY2022	nept	Weighted Average Number Of Shares Outstandings Basic WeightedAverageNumberOfSharesOutstandingsBasic	5958266
CY2022	nept	Weighted Average Number Of Diluted Shares Outstandings WeightedAverageNumberOfDilutedSharesOutstandings	5958266
CY2023	nept	Loss Per Share Attributable To Equity Holders Of Corporation Basic LossPerShareAttributableToEquityHoldersOfCorporationBasic	-5.12
CY2023	nept	Loss Per Share Attributable To Equity Holders Of Corporation Diluted LossPerShareAttributableToEquityHoldersOfCorporationDiluted	-5.12
CY2022	nept	Loss Per Share Attributable To Equity Holders Of Corporation Basic LossPerShareAttributableToEquityHoldersOfCorporationBasic	-15.54
CY2022	nept	Loss Per Share Attributable To Equity Holders Of Corporation Diluted LossPerShareAttributableToEquityHoldersOfCorporationDiluted	-15.54
CY2023	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-1613797
CY2022	us-gaap	Increase Decrease In Accounts And Other Receivables IncreaseDecreaseInAccountsAndOtherReceivables	-163066
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2458170
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-279770
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2018463
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2674208
CY2023	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	7349432
CY2022	us-gaap	Increase Decrease In Accounts Payable Related Parties IncreaseDecreaseInAccountsPayableRelatedParties	2654024
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-285004
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1563113
CY2023	nept	Increase Decrease In Provisions IncreaseDecreaseInProvisions	1932084
CY2022	nept	Increase Decrease In Provisions IncreaseDecreaseInProvisions	-1137281
CY2023	nept	Common Shares And Warrants Issued In Connection With Debt Financing Non Cash Transaction CommonSharesAndWarrantsIssuedInConnectionWithDebtFinancingNonCashTransaction	845736
CY2023	nept	Common Shares Issued In Exchange Of Services Rendered By Non Employees Non Cash Tracnsaction CommonSharesIssuedInExchangeOfServicesRenderedByNonEmployeesNonCashTracnsaction	156975
CY2023Q1	nept	Measurement Of Call Option MeasurementOfCallOption	0
CY2022Q1	nept	Measurement Of Call Option MeasurementOfCallOption	0
CY2023	us-gaap	Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earnings FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings	0
CY2022	us-gaap	Fair Value Assets And Liabilities Measured On Recurring Basis Gain Loss Included In Earnings FairValueAssetsAndLiabilitiesMeasuredOnRecurringBasisGainLossIncludedInEarnings	-5598198
CY2020Q1	nept	Term Of Minimum Annual Volume Of Sales To Maintain Exclusivity Of Specialty Ingredient TermOfMinimumAnnualVolumeOfSalesToMaintainExclusivityOfSpecialtyIngredient	P8Y
CY2020Q1	nept	Remaining Amount Of Minimum Royalties RemainingAmountOfMinimumRoyalties	1149498
CY2023Q1	us-gaap	Payments For Legal Settlements PaymentsForLegalSettlements	500000
CY2023	nept	Number Of Instalments For Litigation Settlement Expense Payable NumberOfInstalmentsForLitigationSettlementExpensePayable	2
CY2023Q1	nept	Litigation Settlement Expense Payable In Installment LitigationSettlementExpensePayableInInstallment	500000
CY2023Q1	nept	Litigation Settlement Expense Payable In Shares LitigationSettlementExpensePayableInShares	2750000
CY2022Q3	us-gaap	Loss Contingency Damages Awarded Value LossContingencyDamagesAwardedValue	68000
CY2022Q4	nept	Additional Unspecified Damage Amount AdditionalUnspecifiedDamageAmount	175534
CY2022Q4	nept	Estimated Excess Damage Amount EstimatedExcessDamageAmount	1000000
CY2023Q1	nept	Breach Of Contract Damage Amount BreachOfContractDamageAmount	328168
CY2023	us-gaap	Revenues Revenues	52615338
CY2022	us-gaap	Revenues Revenues	48797124
CY2023	nept	Number Of Customers NumberOfCustomers	1
CY2022	nept	Number Of Customers NumberOfCustomers	1
CY2023	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	51744817
CY2022	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	47695828
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	1403264
CY2022Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21448123
CY2023Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	1607089
CY2022Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	21655035
CY2023Q1	us-gaap	Goodwill Goodwill	2426385
CY2022Q1	us-gaap	Goodwill Goodwill	22168288
CY2023	us-gaap	Royalty Expense RoyaltyExpense	0
CY2022	us-gaap	Royalty Expense RoyaltyExpense	0
CY2023	us-gaap	Debt Instrument Interest Rate Terms DebtInstrumentInterestRateTerms	The note maturity has been extended from February 1, 2024 to December 31, 2024, which will bear interest at the rate of 15.0% per annum through and including December 31, 2023, payable in kind, and 10.0% per annum, payable in kind, and 5.0% per annum payable in cash, from and after January 1, 2024.
CY2023	nept	Warrant Amendment Description WarrantAmendmentDescription	In connection with this offering, the Company has agreed that certain existing warrants to purchase up to an aggregate of 8,423,733 common shares that were previously issued in March 2022, June 2022, and October 2022, at exercise prices ranging from $1.62 to $11.20 per share and expiration dates ranging from September 14, 2023 to June 23, 2029, were amended to reduce the exercise prices of the applicable warrants to $0.33, with expiration dates five years following the closing of the offering, i.e. on May 15, 2028, with the exception of warrants to purchase up to 972,763 common shares which will expire on June 23, 2029 as currently contemplated, as indicated in note 12.
CY2022Q1	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8423733
CY2022Q2	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8423733
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	8423733
CY2023	nept	Class Of Warrant Or Right Expiration Period ClassOfWarrantOrRightExpirationPeriod	P5Y

Files In Submission

Name	View Source	Status
0000950170-23-033091-index-headers.html	Edgar Link	pending
0000950170-23-033091-index.html	Edgar Link	pending
0000950170-23-033091.txt	Edgar Link	pending
0000950170-23-033091-xbrl.zip	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
img136149170_0.jpg	Edgar Link	pending
img136149170_1.jpg	Edgar Link	pending
img136149170_2.jpg	Edgar Link	pending
img136149170_3.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nept-20230331.htm	Edgar Link	pending
nept-20230331.xsd	Edgar Link	pending
nept-ex23_1.htm	Edgar Link	pending
nept-ex31_1.htm	Edgar Link	pending
nept-ex31_2.htm	Edgar Link	pending
nept-ex32.htm	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R100.htm	Edgar Link	pending
R101.htm	Edgar Link	pending
R102.htm	Edgar Link	pending
R103.htm	Edgar Link	pending
R104.htm	Edgar Link	pending
R105.htm	Edgar Link	pending
R106.htm	Edgar Link	pending
R107.htm	Edgar Link	pending
R108.htm	Edgar Link	pending
R109.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R110.htm	Edgar Link	pending
R111.htm	Edgar Link	pending
R112.htm	Edgar Link	pending
R113.htm	Edgar Link	pending
R114.htm	Edgar Link	pending
nept-20230331_cal.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
nept-20230331_def.xml	Edgar Link	unprocessable
nept-20230331_lab.xml	Edgar Link	unprocessable
nept-20230331_pre.xml	Edgar Link	unprocessable
nept-20230331_htm.xml	Edgar Link	completed
R115.htm	Edgar Link	pending
R116.htm	Edgar Link	pending
R117.htm	Edgar Link	pending
R118.htm	Edgar Link	pending
R119.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R120.htm	Edgar Link	pending
R121.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
R93.htm	Edgar Link	pending
R94.htm	Edgar Link	pending
R95.htm	Edgar Link	pending
R96.htm	Edgar Link	pending
R97.htm	Edgar Link	pending
R98.htm	Edgar Link	pending
R99.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

Neptune Wellness Solutions Inc.

2023 Q4 Form 10-K Financial Statement

#000095017023033091 Filed on July 17, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission